Loading...

Sanofi

SNYNASDAQ
Healthcare
Drug Manufacturers - General
$46.78
$-0.75(-1.58%)
U.S. Market opens in 15h 23m

Sanofi (SNY) Stock Overview

Explore Sanofi’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap113B
P/E Ratio12.51
EPS (TTM)$2.32
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$37.02
3 Months$44.27
1 Year Target$49.31

SNY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Sanofi (SNY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 49.88, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $49.31.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 12.51 and a market capitalization of 113B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.58%
5-Day Change
-3.49%
1-Month Change
3.63%
3-Month Change
-0.89%
6-Month Change
-9.41%
Year-to-Date (YTD) Change
-3.47%
1-Year Change
-12.63%
3-Year Change
-17.36%
5-Year Change
-9.81%
All-Time (Max) Change
57.14%

Contact Information

33 1 53 77 40 00
54, Rue La BoEtie, Paris, NaN, 75008

Company Facts

82,878 Employees
IPO DateJul 1, 2002
CountryFR
Actively Trading

Frequently Asked Questions